EFFICACY AND SAFETY OF CGS 16617, A NEW NONTHIOL ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, IN PATIENTS WITH MILD TO MODERATE HYPERTENSION

被引：0
|
作者：
DESILVA, JK
HURLEY, ME
WECLAWHAKIM, CM
RIBEIRO, LGT
机构：
[1] CIBA GEIGY CORP,SUMMIT,NJ 07901
[2] THOMAS JEFFERSON UNIV,PHILADELPHIA,PA 19107
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：717 / 717
页数：1
相关论文
共 50 条
  • [41] THE SAFETY OF ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS IN MODERATE HYPERTENSION
    GIRARD, M
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1991, 10 (03): : 169 - 185
  • [42] THE EFFECTS OF BENAZEPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN MILD TO MODERATE ESSENTIAL-HYPERTENSION - A MULTICENTER STUDY
    MOSER, M
    ABRAHAM, PA
    BENNETT, WM
    BRACHFELD, N
    GOODMAN, RP
    MCKENNEY, JM
    HOLLIFIELD, JW
    KIRKENDALL, WM
    LASSETER, KC
    LEON, AS
    LUNN, JA
    MILLER, K
    MORGANROTH, J
    RUDDY, MC
    SAMBHI, MP
    STEIN, WJ
    WEBER, MA
    WILLIAMS, RL
    ZAWADA, ET
    DESILVA, J
    GOURLEY, LA
    WHALEN, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (03) : 322 - 329
  • [43] MICROALBUMINURIA IN PATIENTS WITH ESSENTIAL-HYPERTENSION - EFFECTS OF AN ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR AND OF A CALCIUM-CHANNEL BLOCKER
    BIANCHI, S
    BIGAZZI, R
    BALDARI, G
    CAMPESE, VM
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (04) : 291 - 296
  • [44] AN OPEN MULTICENTER STUDY TO ASSESS THE LONG-TERM EFFICACY, TOLERANCE, AND SAFETY OF THE ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR RAMIPRIL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
    BAUER, B
    LORENZ, H
    ZAHLTEN, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S70 - S74
  • [45] QUINAPRIL, AN ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, PREVENTS CARDIAC-HYPERTROPHY DURING EPISODIC HYPERTENSION
    JULIUS, S
    LI, Y
    BRANT, D
    KRAUSE, L
    TAYLOR, D
    HYPERTENSION, 1991, 17 (06) : 1161 - 1166
  • [46] EFFECT OF A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, CILAZAPRIL, ON CIRCULATING ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    KOHNO, M
    YASUNARI, K
    MURAKAWA, K
    YOKOKAWA, K
    HORIO, T
    KURIHARA, N
    TAKEDA, T
    JOURNAL OF HYPERTENSION, 1989, 7 : S298 - S299
  • [47] CGS-13945 - A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN NORMAL VOLUNTEERS
    DESCOMBES, BJ
    TURINI, GA
    BRUNNER, HR
    PORCHET, M
    CHEN, DS
    BENSEN, S
    KIDNEY INTERNATIONAL, 1983, 23 (06) : 901 - 901
  • [48] CGS-13945 - A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN NORMAL VOLUNTEERS
    DESCOMBES, BJ
    TURINI, GA
    BRUNNER, HR
    PORCHET, M
    CHEN, DS
    SEN, SB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 203 - 203
  • [49] INITIAL EVALUATION OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR CGS 13945 IN HYPERTENSIVE PATIENTS
    SCHALLER, MD
    WAEBER, B
    NUSSBERGER, J
    BRUNNER, HR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 37 (05): : 843 - 852
  • [50] TREATMENT OF MILD TO MODERATE HYPERTENSION WITH OR WITHOUT THE CONVERTING-ENZYME-INHIBITOR ENALAPRIL - RESULTS OF A 6-MONTH DOUBLE-BLIND TRIAL
    SASSANO, P
    CHATELLIER, G
    BILLAUD, E
    ALHENCGELAS, F
    CORVOL, P
    MENARD, J
    AMERICAN JOURNAL OF MEDICINE, 1987, 83 (02): : 227 - 235
12345